Molly Henderson
2022 - Phathom Pharmaceuticals
In 2022, Molly Henderson earned a total compensation of $2.6M as Chief Accounting Officer at Phathom Pharmaceuticals.
Compensation breakdown
| Bonus | $75,000 |
|---|---|
| Non-Equity Incentive Plan | $226,152 |
| Option Awards | $1,977,270 |
| Salary | $356,615 |
| Other | $13,500 |
| Total | $2,648,537 |
Henderson received $2M in option awards, accounting for 75% of the total pay in 2022.
Henderson also received $75K in bonus, $226.2K in non-equity incentive plan, $356.6K in salary and $13.5K in other compensation.
Rankings
In 2022, Molly Henderson's compensation ranked 1,384th out of 5,676 executives tracked by ExecPay. In other words, Henderson earned more than 75.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,384 out of 5,676 | 76th |
Division Manufacturing | 684 out of 3,084 | 78th |
Major group Chemicals And Allied Products | 258 out of 1,399 | 82nd |
Industry group Drugs | 237 out of 1,300 | 82nd |
Industry Pharmaceutical Preparations | 166 out of 942 | 82nd |
Source: SEC filing on April 13, 2023.
Henderson's colleagues
We found two more compensation records of executives who worked with Molly Henderson at Phathom Pharmaceuticals in 2022.
News
Phathom Pharmaceuticals CEO Terrie Curran's 2023 pay falls 32% to $3.4M
April 12, 2024
Phathom Pharmaceuticals CEO Terrie Curran's 2022 pay slips 20% to $5M
April 13, 2023
UroGen Pharma Ltd. CEO Elizabeth Barrett's 2020 pay falls 90% to $2.5M
April 28, 2021
Advaxis CEO Kenneth Berlin's 2020 pay jumps 21% to $1.2M
April 21, 2021